Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

Affiliations

• ¹ Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan. [email protected].
• ² National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
• ³ Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomiokahigashi, Kanazawa-ku, Yokohama-shi, Kanagawa, 236-0051, Japan.
• ⁴ Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama, 710-8602, Japan.
• ⁵ Kindai University Hospital, 3-4-1 Kowakae, Higashiosaka, Osaka, 577-8502, Japan.
• ⁶ Miyagi Cancer Center, 47-1 Nodayama, Shiote, Medeshima, Natori, Miyagi, 981-1293, Japan.
• ⁷ Department of Respiratory Medicine, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan.
• ⁸ Niigata Cancer Center Hospital, 2-15-3 Kawagishi-cho, Chuo-ku, Niigata, 951-8566, Japan.
• ⁹ Okayama University Hospital, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
• ¹⁰ Sendai Kousei Hospital, 4-15 Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan.
• ¹¹ Osaka City General Hospital, 2-13-22 Miyakojima Hondori, Miyakojima Ward, Osaka, 534-0021, Japan.
• ¹² Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
• ¹³ Kanazawa University Hospital, 13-1 Takaramachi, Kanazawa, Ishikawa, 920-8641, Japan.
• ¹⁴ Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Sunto-Gun, Shizuoka, 411-8777, Japan.
• ¹⁵ Bristol Myers Squibb, Princeton, NJ, USA.
• ¹⁶ Saitama Cancer Center, 780 Oaza Komuro, Ina Machi, Kita-Adachi-gun, Saitama, 362-0806, Japan.